NMPA Approves TINGSN Technology’s Disposable Intracardiac Ultrasound Diagnostic Catheter
The National Medical Products Administration (NMPA) has granted market approval to TINGSN Technology, a China-based...
The National Medical Products Administration (NMPA) has granted market approval to TINGSN Technology, a China-based...
Jenscare Scientific Co., Ltd. (HKG: 9877), a Ningbo-based manufacturer of devices for structural heart disease,...
Germany-headquartered Bayer (ETR: BAYN) announced the termination of a late-stage trial for its antithrombotic candidate...
China-based Venus Medtech (Hangzhou) Inc., (HKG: 2500), has entered into a strategic partnership with Valgen...
China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has announced that the National Medical...
Sino Medical Sciences Technology Inc., (SHA: 688108) a leading China-based medical device company, has announced...
The China-based EOC Pharma Group has achieved a significant milestone with the National Medical Products...
Hansoh Pharmaceutical (HKG: 3692) has announced that its affiliated company’s self-developed Class 1 new drug,...
Novo Nordisk (CPH: NOVO-B), a leading pharmaceutical company, last week announced a substantial plan to...
Sino Medical Sciences Technology Inc., (SHA: 688108), a Chinese medical technology company, has announced that...
Jenscare Scientific Co., Ltd (HKG: 9877), a leading structural heart disease device manufacturer based in...
MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a spin-off of China-based MicroPort Scientific Corp (HKG:...
Bristol-Myers Squibb (BMS; NYSE: BMY) is set to regain full control of mavacamten, a treatment...
Jenscare Scientific Co., Ltd (HKG: 9877), a leading device maker specializing in structural heart disease...
China-based cardiovascular disease solutions provider Lepu Medical Technology (Beijing) Co., Ltd (SHE: 300003) has announced...
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) announced a significant deal this week, valued at...
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has decided to discontinue a Phase III global...
Sino Medical Sciences Technology Inc., (SHA: 688108), a leading medical device company based in China,...
Global healthcare company Novo Nordisk (NYSE: NVO) and drug discovery alliance Evotec (NASDAQ: EVO) have...
Sino Medical Sciences Technology Inc., (SHA: 688108), a leading Chinese medical device company, has announced...